Abstract
The objective: to investigate the clinical efficacy of the drug Tivomax (arginine hydrochloride 42 mg/ml) at a dose of 100 ml intravenously 1 time a day course 10 days for medical correction of placental dysfunction. Patients and methods. Under our supervision there were 30 pregnant women at term 32-34 weeks with circulatory disorders in the system mother-placenta-fetus. To assess the functional state of the fetoplacental complex used sonometric methods, Doppler Velocimetry of blood flow in the placental system and the definition of biophysical profile of the fetus. Results. The study of peculiarities of haemodynamics in the mother-placenta-fetus was discovered isolated changes in blood flow of uterine arteries in 14 (46.7%) women, accompanied by: a decrease in the diastolic component in the end-diastolic velocity krovotoka – 42.3±2.14 cm/s, increased resistance index – 0.65±0.08 and systolo-diastolic ratio was 2.47±0.32. Violation of placental blood flow was observed in 11 (36.7%) patients. All the patients for the correction of violations was given the drug Tivomax. Conclusion. Tivomax as a donor L-arginine has pronounced effect on the vascular tone as the uterine arteries, and arteries of the umbilical cord, contributing to the normalization of hemodynamics in the mother-placenta-fetus. Key words: Tivomax, L-arginine, endothelium. Obstetrics and gynecology, placental deficiency, preeclampsia
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
